Literature DB >> 16537893

Cooperative DNA binding with AP-1 proteins is required for transformation by EWS-Ets fusion proteins.

Sungeun Kim1, Christopher T Denny, Ron Wisdom.   

Abstract

A key molecular event in the genesis of Ewing's sarcoma is the consistent presence of chromosomal translocations that result in the formation of proteins in which the amino terminus of EWS is fused to the carboxyl terminus, including the DNA binding domain, of one of five different Ets family proteins. These fusion proteins function as deregulated transcription factors, resulting in aberrant control of gene expression. Recent data indicate that some EWS-Ets target promoters, including the uridine phosphorylase (UPP) promoter, harbor tandem binding sites for Ets and AP-1 proteins. Here we show that those Ets family proteins that participate in Ewing's sarcoma, including Fli1, ERG, and ETV1, cooperatively bind these tandem elements with Fos-Jun while other Ets family members do not. Analysis of this cooperativity in vitro shows that (i) many different spatial arrangements of the Ets and AP-1 sites support cooperative binding, (ii) the bZIP motifs of Fos and Jun are sufficient to support this cooperativity, and (iii) both the Ets domain and carboxy-terminal sequences of Fli1 are important for cooperative DNA binding. EWS-Fli1 activates the expression of UPP mRNA, is directly bound to the UPP promoter, and transforms 3T3 fibroblasts; in contrast, a C-terminally truncated mutant form of EWS-Fli1 that cannot cooperatively bind DNA with Fos-Jun is defective in all of these properties. The results show that the ability of EWS-Ets proteins to cooperatively bind DNA with Fos-Jun is critical to the biologic activities of these proteins. The results have implications for understanding the pathogenesis of Ewing's sarcoma. In addition, they may be relevant to the mechanisms of Ras-dependent activation of genes that harbor tandem Ets and AP-1 binding sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537893      PMCID: PMC1430316          DOI: 10.1128/MCB.26.7.2467-2478.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Structural studies of Ets-1/Pax5 complex formation on DNA.

Authors:  C W Garvie; J Hagman; C Wolberger
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

Review 2.  Biology of EWS/ETS fusions in Ewing's family tumors.

Authors:  A Arvand; C T Denny
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

Review 3.  Autoinhibitory domains: modular effectors of cellular regulation.

Authors:  Miles A Pufall; Barbara J Graves
Journal:  Annu Rev Cell Dev Biol       Date:  2002-04-02       Impact factor: 13.827

4.  Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.

Authors:  T L Goetz; T L Gu; N A Speck; B J Graves
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

5.  RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.

Authors:  Ron Wisdom; Lyanne Huynh; Datsun Hsia; Sungeun Kim
Journal:  Oncogene       Date:  2005-10-27       Impact factor: 9.867

6.  The COOH-terminal domain of FLI-1 is necessary for full tumorigenesis and transcriptional modulation by EWS/FLI-1.

Authors:  A Arvand; S M Welford; M A Teitell; C T Denny
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

7.  The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex.

Authors:  M Hassler; T J Richmond
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

8.  HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.

Authors:  D G Bosc; B S Goueli; R Janknecht
Journal:  Oncogene       Date:  2001-09-27       Impact factor: 9.867

9.  Crystal structure of PU.1/IRF-4/DNA ternary complex.

Authors:  Carlos R Escalante; Abraham L Brass; Jagan M R Pongubala; Ella Shatova; Leyi Shen; Harinder Singh; Aneel K Aggarwal
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

Review 10.  Mouse models in the study of the Ets family of transcription factors.

Authors:  F O Bartel; T Higuchi; D D Spyropoulos
Journal:  Oncogene       Date:  2000-12-18       Impact factor: 9.867

View more
  29 in total

Review 1.  Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma.

Authors:  Hayriye V Erkizan; Vladimir N Uversky; Jeffrey A Toretsky
Journal:  Clin Cancer Res       Date:  2010-06-14       Impact factor: 12.531

Review 2.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-09-25       Impact factor: 8.250

3.  Oncogenic ETS proteins mimic activated RAS/MAPK signaling in prostate cells.

Authors:  Peter C Hollenhorst; Mary W Ferris; Megan A Hull; Heejoon Chae; Sun Kim; Barbara J Graves
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

Review 4.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

5.  Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites.

Authors:  Bethany J Madison; Kathleen A Clark; Niraja Bhachech; Peter C Hollenhorst; Barbara J Graves; Simon L Currie
Journal:  J Biol Chem       Date:  2018-10-12       Impact factor: 5.157

6.  Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors.

Authors:  Hayriye V Erkizan; Lauren J Scher; S Ellen Gamble; Julie S Barber-Rotenberg; Kamal P Sajwan; Aykut Üren; Jeffrey A Toretsky
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

7.  EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice.

Authors:  Enrique C Torchia; Kelli Boyd; Jerold E Rehg; Chunxu Qu; Suzanne J Baker
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

Review 8.  The oncogene ERG: a key factor in prostate cancer.

Authors:  P Adamo; M R Ladomery
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

Review 9.  Oxidative stress as a mediator of cardiovascular disease.

Authors:  Maqsood M Elahi; Yu Xiang Kong; Bashir M Matata
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

10.  Mesenchymal Stem Cells and the Origin of Ewing's Sarcoma.

Authors:  Patrick P Lin; Yongxing Wang; Guillermina Lozano
Journal:  Sarcoma       Date:  2010-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.